Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Monograph series

Neuroactive peptides

Peptides supplied for cognitive, anxiolytic and sleep-related indications.

Monographs in this series

4 documents
  • CEI-MN-038Neuroactive peptidesUnapproved, research supply3 assessed outcomesversion 1.2

    DSIP was isolated on the hypothesis that it mediated sleep induction. Subsequent work has not established a receptor, a consistent pharmacological effect, or a physiological role, and the somnogenic activity that gave the peptide…

    Very low24 May 2026
  • CEI-MN-039Neuroactive peptidesUnapproved, research supply3 assessed outcomesversion 1.2

    Epithalon is supplied on the premise that it activates telomerase and thereby extends replicative lifespan, on the basis of cell-culture reports of telomerase induction in human somatic cells. The Institute notes that telomerase…

    Very low26 Jan 2025
  • CEI-MN-037Neuroactive peptidesApproved1 assessed outcomeversion 1.0

    Selank is reported to produce anxiolysis without sedation or dependence, attributed to modulation of GABAergic transmission and to inhibition of enkephalin degradation. It also carries the immunomodulatory activity of the tuftsin…

    Low09 Feb 2026
  • CEI-MN-036Neuroactive peptidesApproved2 assessed outcomesversion 1.0

    Semax is reported to increase expression of brain-derived neurotrophic factor and its receptor TrkB in rodent hippocampus, and to modulate monoaminergic transmission. Its approved Russian indications are ischaemic stroke and…

    Low19 Apr 2026
Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.